Erratum: A randomized, double-blind, placebo-controlled study of rapid-acting intramuscular olanzapine in Japanese patients for schizophrenia with acute agitation.
Lilly Research Laboratories Japan, Eli Lilly Japan K.K, Kobe, Japan. katagiri_hideaki@lilly.com.
Hideaki
H
Katagiri
Lilly Research Laboratories Japan, Eli Lilly Japan K.K, Kobe, Japan. fujikoshi_shinji@lilly.com.
Shinji
S
Fujikoshi
Ayase Hospital, 6-3-1 Ayase, Adachi-ku, Tokyo, 120-0005, Japan. takuya-s@pop01.odn.ne.jp.
Takuya
T
Suzuki
Seishinkai Okehazama Hospital Fujita Kokoro Care Center, 3-879 Sakaecho Minamiyakata, Toyoake-shi, Aichi, 470-1168, Japan. kiyoshif@rg8.so-net.ne.jp.
Kiyoshi
K
Fujita
Numazu Chuo Hospital, 24-1 Nakasecho, Numazu-shi, Shizuoka, 410-0811, Japan. naoyasug@numazuchuo.jp.
Naoya
N
Sugiyama
Lilly Research Laboratories Japan, Eli Lilly Japan K.K, Kobe, Japan. takahashi_michihiro@lilly.com.|Takahashi Psychiatric Clinic, Ashiya, Hyogo, Japan. takahashi_michihiro@lilly.com.
Michihiro
M
Takahashi
Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, IN, 46285, USA. gomez_juan-carlos@lilly.com.
Juan-Carlos
JC
Gomez